VENTANA PAN-TRK (EPR17341) ASSAY
VENTANA PAN-TRK (EPR17341) ASSAY ESTÁ DESTINADO A LA DETECCIÓN INMUNOHISTOQUÍMICA DE LA REGIÓN C-TERMINAL DE LAS PROTEÍNAS A, B Y C DEL RECEPTOR DE LA TROPOMIOSINA QUINASA (TRK), QUE SE SABE QUE SE CONSERVA EN LAS PROTEÍNAS DE FUSIÓN QUIMÉRICAS Y NATURALE
PAN-TRK WINDOW (EPR17341) ASSAY IS INTENDED FOR THE IMMUNOHISTOCHEMICAL DETECTION OF THE C-TERMINAL REGION OF TROPOMYOSIN KINASE RECEPTOR (TRK) PROTEINS A, B AND C, WHICH IS KNOWN TO BE CONSERVED IN CHIMERIC AND NATURAL FUSION PROTEINS.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ANTICUERPO MONOCLONAL
- Trade Name (English)
- MONOCLONAL ANTIBODY
- Analysis ID
- 1768R2019 SSA
- Registration Date
- August 28, 2019
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for VENTANA PAN-TRK (EPR17341) ASSAY (VENTANA PAN-TRK (EPR17341) ASSAY) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1768R2019 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on August 28, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.